NASDAQ : GNTA
Genenta Science S.p.A. — Financial statements
Healthcare · Biotechnology · Italy
Last price 0.62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 29.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 3.90M | 3.90M | 4.95M | 5.26M | 5.71M | 2.30M |
| Research & Development | 2.70M | 2.70M | 4.81M | 6.47M | 5.34M | 3.39M |
| Operating Expenses | 6.60M | 6.60M | 9.76M | 11.73M | 11.04M | 5.69M |
| Operating Income | -6.60M | -6.60M | -9.76M | -11.73M | -11.04M | -5.69M |
| Interest Expense | -11.72K | |||||
| Interest & Investment Income | 619.96K | 619.96K | 610.82K | 309.25K | 36.98K | |
| Currency Exchange Gain (Loss) | -546.05K | -546.05K | 240.99K | -216.89K | 2.29M | |
| Other Non Operating Income (Expenses) | -4.88K | 242.55K | 19.66K | |||
| EBT Excluding Unusual Items | -6.53M | -6.53M | -8.91M | -11.65M | -8.48M | -5.68M |
| Other Unusual Items | 150.00K | |||||
| Pretax Income | -6.53M | -6.53M | -8.91M | -11.65M | -8.48M | -5.53M |
| Net Income | -6.53M | -6.53M | -8.91M | -11.65M | -8.48M | -5.53M |
| Net Income to Common | -6.53M | -6.53M | -8.91M | -11.65M | -8.48M | -5.53M |
| Shares Outstanding (Basic) | 19.71M | 19.71M | 18.27M | 18.22M | 18.22M | 15.08M |
| Shares Outstanding (Diluted) | 19.71M | 19.71M | 18.27M | 18.22M | 18.22M | 15.08M |
| EPS (Basic) | -0.33 | -0.33 | -0.49 | -0.64 | -0.47 | -0.37 |
| EPS (Diluted) | -0.33 | -0.33 | -0.49 | -0.64 | -0.47 | -0.37 |
| Free Cash Flow | -6.88M | -6.88M | -6.24M | -11.22M | -7.45M | -6.97M |
| Free Cash Flow Per Share | -0.35 | -0.35 | -0.34 | -0.62 | -0.41 | -0.46 |
| EBITDA | -6.58M | -6.58M | -9.72M | -11.69M | -11.04M | -5.68M |
| D&A For EBITDA | 28.08K | 28.08K | 44.52K | 42.45K | 6.14K | 4.89K |
| EBIT | -6.60M | -6.60M | -9.76M | -11.73M | -11.04M | -5.69M |
Balance sheet
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.53M | 5.53M | 4.58M | 3.69M | 29.79M | 37.24M |
| Short-Term Investments | 22.62M | 22.62M | 8.08M | 15.08M | ||
| Cash & Short-Term Investments | 28.15M | 28.15M | 12.66M | 18.78M | 29.79M | 37.24M |
| Other Receivables | 1.29M | 1.29M | 1.45M | 2.00M | 1.56M | 1.42M |
| Receivables | 1.29M | 1.29M | 1.45M | 2.00M | 1.56M | 1.42M |
| Prepaid Expenses | 190.92K | 190.92K | 117.99K | 378.15K | 103.54K | 18.25K |
| Other Current Assets | 353.81K | 353.81K | 246.82K | 98.77K | 260.55K | 80.00K |
| Total Current Assets | 29.98M | 29.98M | 14.47M | 21.26M | 31.72M | 38.76M |
| Property, Plant & Equipment | 22.46K | 22.46K | 42.92K | 82.98K | 111.64K | 23.09K |
| Other Long-Term Assets | 1.89M | 1.89M | 308.09K | 1.01M | 1.60M | 1.24M |
| Total Assets | 31.89M | 31.89M | 14.82M | 22.35M | 33.44M | 40.03M |
| Accounts Payable | 1.81M | 1.81M | 497.95K | 465.86K | 1.19M | 189.87K |
| Accrued Expenses | 189.29K | 189.29K | 1.26M | 1.01M | 691.60K | 844.45K |
| Other Current Liabilities | 119.00K | 119.00K | 337.76K | 255.06K | 297.88K | 100.72K |
| Total Current Liabilities | 2.12M | 2.12M | 2.10M | 1.74M | 2.18M | 1.14M |
| Long-Term Debt | 7.60M | 7.60M | ||||
| Pension & Post-Retirement Benefits | 327.79K | 327.79K | 227.77K | 164.66K | 88.96K | 30.62K |
| Other Long-Term Liabilities | 1.16K | 14.59K | 27.22K | |||
| Total Liabilities | 10.05M | 10.05M | 2.33M | 1.91M | 2.30M | 1.17M |
| Common Stock | 84.26M | 84.26M | 68.46M | 67.34M | 66.60M | 65.88M |
| Retained Earnings | -62.59M | -62.59M | -56.06M | -47.14M | -35.47M | -27.02M |
| Comprehensive Income & Other | 166.51K | 166.51K | 88.95K | 231.14K | ||
| Shareholders' Equity | 21.84M | 21.84M | 12.50M | 20.43M | 31.14M | 38.86M |
| Total Liabilities & Equity | 31.89M | 31.89M | 14.82M | 22.35M | 33.44M | 40.03M |
| Total Debt | 7.60M | 7.60M | ||||
| Net Cash (Debt) | 20.55M | 20.55M | 12.66M | 18.78M | 29.79M | 37.24M |
| Net Cash Per Share | 1.04 | 1.04 | 0.69 | 1.03 | 1.64 | 2.47 |
| Filing Date Shares Outstanding | 23.59M | 23.59M | 18.29M | 18.22M | 18.22M | 18.22M |
| Total Common Shares Outstanding | 23.43M | 23.43M | 18.29M | 18.22M | 18.22M | 18.22M |
| Working Capital | 27.86M | 27.86M | 12.37M | 19.52M | 29.54M | 37.62M |
| Book Value Per Share | 0.93 | 0.93 | 0.68 | 1.12 | 1.71 | 2.13 |
| Tangible Book Value | 21.84M | 21.84M | 12.50M | 20.43M | 31.14M | 38.86M |
| Tangible Book Value Per Share | 0.93 | 0.93 | 0.68 | 1.12 | 1.71 | 2.13 |
| Machinery | 61.07K | 61.07K | 53.45K | 48.98K | 35.98K | 29.88K |
Cash flow statement
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -6.53M | -6.53M | -8.91M | -11.65M | -8.48M | -5.53M |
| Depreciation & Amortization | 28.08K | 28.08K | 44.52K | 42.45K | 6.14K | 4.89K |
| Loss (Gain) From Sale of Investments | 103.00K | 103.00K | ||||
| Stock-Based Compensation | 1.01M | 1.01M | 847.25K | 739.88K | 722.74K | 497.10K |
| Other Operating Activities | 100.02K | 100.02K | 63.11K | 75.69K | 90.36K | 13.23K |
| Change in Accounts Payable | 1.31M | 1.31M | 32.08K | -728.18K | 1.00M | -365.15K |
| Change in Other Net Operating Assets | -2.89M | -2.89M | 1.69M | 310.58K | -763.88K | -1.58M |
| Operating Cash Flow | -6.87M | -6.87M | -6.24M | -11.21M | -7.42M | -6.96M |
| Capital Expenditures | -7.62K | -7.62K | -4.47K | -13.79K | -27.07K | -9.01K |
| Investment in Securities | -14.54M | -14.54M | 6.89M | -14.88M | ||
| Investing Cash Flow | -14.54M | -14.54M | 6.88M | -14.89M | -27.07K | -9.01K |
| Long-Term Debt Issued | 7.50M | 7.50M | ||||
| Net Debt Issued (Repaid) | 7.50M | 7.50M | ||||
| Issuance of Common Stock | 28.74M | |||||
| Other Financing Activities | 14.79M | 14.79M | 270.88K | 531.00 | ||
| Financing Cash Flow | 22.29M | 22.29M | 270.88K | 531.00 | 28.74M | |
| Foreign Exchange Rate Adjustments | 70.36K | 70.36K | -23.45K | -6.28K | ||
| Net Cash Flow | 945.92K | 945.92K | 890.33K | -26.10M | -7.45M | 21.77M |
| Free Cash Flow | -6.88M | -6.88M | -6.24M | -11.22M | -7.45M | -6.97M |
| Free Cash Flow Per Share | -0.35 | -0.35 | -0.34 | -0.62 | -0.41 | -0.46 |
| Levered Free Cash Flow | -3.10M | -3.10M | -4.18M | -7.57M | -5.56M | -4.72M |
| Unlevered Free Cash Flow | -3.10M | -3.10M | -4.18M | -7.57M | -5.56M | -4.71M |
| Change in Working Capital | -1.58M | -1.58M | 1.72M | -417.60K | 240.30K | -1.94M |
Ratios
Fiscal year January - December; amounts in EUR.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 29.81M | 34.91M | 79.56M | 90.17M | 100.19M | 198.63M |
| Enterprise Value | 5.69M | 23.04M | 61.47M | 65.96M | 64.00M | 186.11M |
| Last Close Price | 0.62 | 1.49 | 4.35 | 4.95 | 5.50 | 10.96 |
| PB Ratio | 0.56 | 1.36 | 6.15 | 3.99 | 3.01 | 4.49 |
| P/TBV Ratio | 1.16 | 1.36 | 6.15 | 3.99 | 3.01 | 4.49 |
| Debt / Equity Ratio | 0.35 | 0.35 | ||||
| Net Debt / Equity Ratio | -0.94 | -0.94 | -1.01 | -0.92 | -0.96 | -0.96 |
| Net Debt / EBITDA Ratio | 3.12 | 3.12 | 1.30 | 1.61 | 2.70 | 6.55 |
| Net Debt / FCF Ratio | 2.99 | 2.99 | 2.03 | 1.67 | 4.00 | 5.34 |
| Quick Ratio | 13.90 | 13.90 | 6.72 | 11.97 | 14.36 | 34.06 |
| Current Ratio | 14.15 | 14.15 | 6.89 | 12.25 | 14.53 | 34.15 |
| Return on Equity (ROE) | -38.03% | -38.03% | -54.13% | -45.16% | -24.22% | -20.47% |
| Return on Assets (ROA) | -17.67% | -17.67% | -32.84% | -26.29% | -18.79% | -12.36% |
| Return on Capital Employed (ROCE) | -22.20% | -22.20% | -76.70% | -56.90% | -35.30% | -14.60% |
| Earnings Yield | -62.91% | -21.96% | -11.60% | -14.27% | -9.04% | -3.17% |
| FCF Yield | -25.85% | -23.12% | -8.13% | -13.75% | -7.94% | -3.99% |
| Buyback Yield / Dilution | -7.86% | -7.86% | -0.31% | 0.00% | -20.77% | -3.74% |